Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlue Star Regulatory News (BLU)

Share Price Information for Blue Star (BLU)

Share Price is delayed by 15 minutes
Get Live Data
7.00    -1.50 (-17.65%)
Bid:
6.50
Ask:
7.50
Spread: 1.00 (15.385%)
Market Cap: £3.33m
BLU Live PriceLast checked at - London Stock Exchange

Intraday Blue Star Share Chart

Loan Update

4 Feb 2013 08:16

RNS Number : 0213X
Blue Star Capital plc
04 February 2013
 



 

 

Blue Star Capital plc

 

("Blue Star Capital" or "the Company")

 

Shareholder Loan Update

 

Blue Star Capital is pleased to announce that further to the announcement dated 3 January 2013, the Company has agreed a further extension to the shareholder loan agreement (the "Loan") entered into on 28 April 2011, and thereafter extended on 1 June 2012, 12 October 2012 and 3 January 2013. The original amount of the Loan was £400,000 which, with the accrued interest at 10% per annum, had been due for repayment by 30 September 2012.

 

Save as set out below, the terms of the Loan remain unchanged, except that repayment, which had been extended to 31 January 2013, has now been deferred until 31 March 2013 (the "Final Redemption Date").

 

Pursuant to the terms of the Loan extension, with effect from 1 February 2013 and until 28 February 2013, the full amount (including interest and repayment premium) to redeem the Loan is £564,916 (the "Revised Principal"). From 1st March 2013, the Revised Principal will accrue interest on a compound basis at a rate of 2.0% per month, or part month.

 

As consideration for agreeing to extend the repayment date of the loan as set out above, the Company has further agreed that the warrants issued to the providers of the Loan at the time of the original loan agreement (the "Warrants") will be amended such that the exercise price of the warrants will be reduced from 2 pence per ordinary share to 0.6 per ordinary share.

 

Anthony Fabrizi and a company connected with Noel Lyons (both individuals being non-executive directors of the Company) are amongst those that are providing the Loan and are each a related party for the purposes of AIM Rule 13. The independent directors of the Company, being The Rt Hon The Lord Dear Kt QPM DL LLB, Peter Varnish OBE and General Sir Michael Wilkes KCB CBE consider, having consulted with the Company's nominated adviser Daniel Stewart & Company plc ("Daniel Stewart"), that the terms of the Loan and Warrants are fair and reasonable insofar as the Company's shareholders are concerned.

 

Corporate strategy update

 

The Directors of the Company are continuing to review various strategic options available to the Company and are in discussions with a number of parties regarding opportunities to improve the Company's immediate cash position and provide it with (i) sufficient funds in order to repay the Shareholder Loan; and (ii) general working capital for the Company. However, the outcome of these discussions is dependent on a number of factors, including the actions of a number of third parties, and are therefore outside of the control of the Company or its Directors and there can be no guarantee as to their success.

 

 

Enquiries:

 

Blue Star Capital plc

Tony Fabrizi

Tel:0777 178 2434

Daniel Stewart & Company plc (Nomad & Joint Broker)

David Hart Director, Corporate Finance

Martin Lampshire, Head of Corporate Broking

Tel: 020 7776 6550

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUCGPUPWURC
Date   Source Headline
20th Jan 202211:05 amRNSSecond Price Monitoring Extn
20th Jan 202211:00 amRNSPrice Monitoring Extension
18th Jan 20227:14 amRNSGuild Sponsorship Deal
17th Jan 20227:00 amRNSSatoshiPay Directorate Changes and Update
6th Jan 202212:07 pmRNSHolding(s) in Company
5th Jan 20227:00 amRNSStatement re Share Price Movement
8th Dec 20213:19 pmRNSHolding(s) in Company
7th Dec 202111:37 amRNSHolding(s) in Company
6th Dec 20218:10 amRNSGuild Signs Top Three FIFA Player
6th Dec 20217:58 amRNSGuild Signs Top Three FIFA Player
3rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
3rd Nov 20212:00 pmRNSPrice Monitoring Extension
2nd Nov 20217:00 amRNSPendulum raises $5 million
13th Oct 20217:00 amRNSFurther re: Option Scheme and Grant of Options
24th Sep 20217:00 amRNSOption Scheme and Grant of Options
25th Aug 20217:00 amRNSHolding(s) in Company
29th Jun 20217:45 amRNSHalf-year Report
7th Jun 20217:00 amRNSSatoshiPay receives R&D Grant for Pendulum
18th May 20214:40 pmRNSHolding(s) in Company
6th May 20217:00 amRNSUpdate on Investment Portfolio
5th May 20217:00 amRNSExercise of Warrants and Director’s Dealing
26th Apr 20212:15 pmRNSHolding(s) in Company
21st Apr 20217:00 amRNSDynasty eSports Investment
16th Apr 20217:58 amRNSExercise of Warrants, Placing and New Investment
15th Apr 20214:29 pmRNSDynasty eSports Update
25th Mar 202111:58 amRNSGuild Esports Investment Update
16th Mar 202112:19 pmRNSHolding(s) in Company
18th Feb 20212:56 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSLeaf Mobile Update
9th Feb 20217:00 amRNSResult of AGM and Directorate Change
14th Jan 20217:00 amRNSChange of Adviser
12th Jan 20217:00 amRNSFinal Results
7th Jan 20214:20 pmRNSHolding(s) in Company
6th Jan 20213:53 pmRNSHolding(s) in Company
6th Jan 20213:50 pmRNSHolding(s) in Company
5th Jan 20214:40 pmRNSSecond Price Monitoring Extn
5th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 202111:20 amRNSHolding(s) in Company
23rd Dec 20207:00 amRNSUpdate on eSport Portfolio
15th Dec 20209:08 amRNSUpdate on SatoshiPay Investment
1st Dec 20207:00 amRNSTotal Voting Rights
9th Nov 202010:04 amRNSReplacement: Exercise of Warrants
9th Nov 20207:00 amRNSExercise of Warrants and Director’s Dealing
6th Oct 20207:00 amRNSDynasty Esports Investment Update
2nd Oct 20204:23 pmRNSTotal Voting Rights
29th Sep 20201:10 pmRNSGuild Esports Investment Update
23rd Sep 20207:00 amRNSFORMATION Esports Investment
22nd Sep 20208:30 amRNSUpdate on SatoshiPay Investment
11th Sep 20207:00 amRNSExercise of Warrants
9th Sep 20207:05 amRNSGuild Esports Investment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.